JP2022527267A5 - - Google Patents
Info
- Publication number
- JP2022527267A5 JP2022527267A5 JP2021557228A JP2021557228A JP2022527267A5 JP 2022527267 A5 JP2022527267 A5 JP 2022527267A5 JP 2021557228 A JP2021557228 A JP 2021557228A JP 2021557228 A JP2021557228 A JP 2021557228A JP 2022527267 A5 JP2022527267 A5 JP 2022527267A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- sequence shown
- hla
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025006913A JP2025062611A (ja) | 2019-03-25 | 2025-01-17 | Ｔ細胞受容体及びその使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962823487P | 2019-03-25 | 2019-03-25 | |
| US62/823,487 | 2019-03-25 | ||
| PCT/IB2020/052776 WO2020194195A1 (en) | 2019-03-25 | 2020-03-24 | T cell receptors and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025006913A Division JP2025062611A (ja) | 2019-03-25 | 2025-01-17 | Ｔ細胞受容体及びその使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022527267A JP2022527267A (ja) | 2022-06-01 |
| JP2022527267A5 true JP2022527267A5 (enExample) | 2023-03-17 |
Family
ID=72611623
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557228A Withdrawn JP2022527267A (ja) | 2019-03-25 | 2020-03-24 | Ｔ細胞受容体及びその使用方法 |
| JP2025006913A Pending JP2025062611A (ja) | 2019-03-25 | 2025-01-17 | Ｔ細胞受容体及びその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025006913A Pending JP2025062611A (ja) | 2019-03-25 | 2025-01-17 | Ｔ細胞受容体及びその使用方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12577287B2 (enExample) |
| EP (1) | EP3947688A4 (enExample) |
| JP (2) | JP2022527267A (enExample) |
| KR (1) | KR20210144782A (enExample) |
| CN (1) | CN113795586B (enExample) |
| AU (1) | AU2020245270A1 (enExample) |
| BR (1) | BR112021018734A2 (enExample) |
| CA (1) | CA3133945A1 (enExample) |
| IL (1) | IL286620A (enExample) |
| MX (1) | MX2021011462A (enExample) |
| SG (1) | SG11202109701SA (enExample) |
| TW (1) | TW202102533A (enExample) |
| WO (1) | WO2020194195A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110950949B (zh) * | 2018-09-26 | 2022-04-05 | 香雪生命科学技术（广东）有限公司 | 一种识别ssx2抗原的t细胞受体 |
| EP3935175A4 (en) | 2019-03-04 | 2023-01-04 | University Health Network | T-LYMPHOCYTE RECEPTORS AND METHODS OF USE THEREOF |
| CN113795584B (zh) | 2019-03-04 | 2025-09-30 | 大学健康网络 | T细胞受体及其使用方法 |
| KR20210144737A (ko) | 2019-03-04 | 2021-11-30 | 유니버시티 헬스 네트워크 | T 세포 수용체 및 이의 사용 방법 |
| MX2021011462A (es) | 2019-03-25 | 2021-12-15 | Univ Health Network | Receptores de linfocitos t y metodos de uso de los mismos. |
| CN112442119B (zh) * | 2019-09-05 | 2023-02-24 | 香雪生命科学技术（广东）有限公司 | 一种识别ssx2的高亲和力t细胞受体 |
| KR20240112285A (ko) * | 2021-11-10 | 2024-07-18 | 티스캔 테라퓨틱스, 인크. | Magea1 면역원성 펩티드, magea1 면역원성 펩티드를 인식하는 결합 단백질 및 이의 용도 |
| CN116063457A (zh) * | 2022-04-27 | 2023-05-05 | 恒瑞源正(广州)生物科技有限公司 | Mage-a1特异性t细胞受体及其用途 |
| CN117946246B (zh) * | 2023-02-23 | 2024-08-06 | 暨南大学 | 一种识别mage-a3抗原短肽的t细胞受体及其应用 |
| WO2025090850A1 (en) * | 2023-10-27 | 2025-05-01 | Tscan Therapeutics, Inc. | Magea1 immunogenic peptides, binding proteins recognizing magea1 immunogenic peptides, and uses thereof |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2323632A1 (en) | 1998-03-13 | 1999-09-16 | Epimmune Inc. | Hla-binding peptides and their uses |
| CA2388337C (en) | 1999-10-22 | 2013-01-08 | Aventis Pasteur Limited | Method of inducing and/or enhancing an immune response to tumor antigens |
| US6506875B1 (en) | 2000-09-26 | 2003-01-14 | Ludwig Institute For Cancer Research | Isolated peptides which bind to HLA-C molecules and uses thereof |
| EP2144935A2 (en) * | 2007-03-29 | 2010-01-20 | Technion Research & Development Foundation Ltd. | Antibodies, methods and kits for diagnosing and treating melanoma |
| KR101363928B1 (ko) * | 2007-06-11 | 2014-02-19 | 고쿠리츠다이가쿠호진 미에다이가쿠 | 특이적 유전자 발현 방법 |
| EP2337795A2 (en) * | 2008-10-01 | 2011-06-29 | Dako Denmark A/S | Mhc multimers in cancer vaccines and immune monitoring |
| DK2352756T3 (da) | 2008-11-24 | 2012-12-03 | Helmholtz Zentrum Muenchen | Højaffin T-cellereceptor og anvendelse af denne |
| WO2010088160A1 (en) * | 2009-01-28 | 2010-08-05 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | T cell receptors and related materials and methods of use |
| JP5756792B2 (ja) * | 2009-04-02 | 2015-07-29 | ヴァクソン バイオテックＶａｘｏｎ Ｂｉｏｔｅｃｈ | 免疫療法のための潜在性ｈｌａ−ａ２４エピトープの同定、最適化及び使用 |
| WO2011140284A2 (en) | 2010-05-04 | 2011-11-10 | Fred Hutchinson Cancer Research Center | Conditional superagonist ctl ligands for the promotion of tumor-specific ctl responses |
| HRP20171164T1 (hr) | 2010-09-20 | 2017-10-20 | Biontech Cell & Gene Therapies Gmbh | Antigen-specifični t stanični receptori i t stanični epitopi |
| PH12013501201A1 (en) | 2010-12-09 | 2013-07-29 | Univ Pennsylvania | Use of chimeric antigen receptor-modified t cells to treat cancer |
| EP3604271A1 (en) | 2013-06-28 | 2020-02-05 | Auckland Uniservices Limited | Peptides for amino acid and peptide conjugates and conjugation process |
| KR101503341B1 (ko) | 2014-03-12 | 2015-03-18 | 국립암센터 | 자가암항원 특이적 cd8+ t 세포의 분리 및 증식방법 |
| US20170333480A1 (en) | 2014-11-05 | 2017-11-23 | Board Of Regents, The University Of Texas System | Gene modified immune effector cells and engineered cells for expansion of immune effector cells |
| NL2014935B1 (en) * | 2015-06-08 | 2017-02-03 | Applied Immune Tech Ltd | T cell receptor like antibodies having fine specificity. |
| DK3399985T3 (da) | 2016-01-06 | 2022-03-21 | Health Research Inc | Sammensætninger og biblioteker, der omfatter rekombinante T-cellereceptorer, og fremgangsmåder til anvendelse af rekombinante T-cellereceptorer |
| JP6692040B2 (ja) * | 2016-11-01 | 2020-05-13 | 学校法人自治医科大学 | 成人ｔ細胞性白血病を含むｈｔｌｖ−１ウイルス感染に対する腫瘍抗原特異的ｔ細胞 |
| WO2020178739A1 (en) | 2019-03-04 | 2020-09-10 | University Health Network | T cell receptors and methods of use thereof |
| JP7748874B2 (ja) | 2019-03-04 | 2025-10-03 | ユニバーシティー ヘルス ネットワーク | Ｔ細胞受容体及びその使用方法 |
| EP3935175A4 (en) | 2019-03-04 | 2023-01-04 | University Health Network | T-LYMPHOCYTE RECEPTORS AND METHODS OF USE THEREOF |
| KR20210144737A (ko) | 2019-03-04 | 2021-11-30 | 유니버시티 헬스 네트워크 | T 세포 수용체 및 이의 사용 방법 |
| KR20210144740A (ko) | 2019-03-04 | 2021-11-30 | 유니버시티 헬스 네트워크 | T 세포 수용체 및 이의 사용 방법 |
| US20220168346A1 (en) | 2019-03-04 | 2022-06-02 | University Health Network | T cell receptors and methods of use thereof |
| CN113795584B (zh) | 2019-03-04 | 2025-09-30 | 大学健康网络 | T细胞受体及其使用方法 |
| MX2021011462A (es) | 2019-03-25 | 2021-12-15 | Univ Health Network | Receptores de linfocitos t y metodos de uso de los mismos. |
-
2020
- 2020-03-24 MX MX2021011462A patent/MX2021011462A/es unknown
- 2020-03-24 BR BR112021018734A patent/BR112021018734A2/pt unknown
- 2020-03-24 CN CN202080031056.7A patent/CN113795586B/zh active Active
- 2020-03-24 AU AU2020245270A patent/AU2020245270A1/en active Pending
- 2020-03-24 EP EP20776939.9A patent/EP3947688A4/en active Pending
- 2020-03-24 WO PCT/IB2020/052776 patent/WO2020194195A1/en not_active Ceased
- 2020-03-24 CA CA3133945A patent/CA3133945A1/en active Pending
- 2020-03-24 JP JP2021557228A patent/JP2022527267A/ja not_active Withdrawn
- 2020-03-24 SG SG11202109701S patent/SG11202109701SA/en unknown
- 2020-03-24 KR KR1020217033984A patent/KR20210144782A/ko not_active Ceased
- 2020-03-24 US US17/598,763 patent/US12577287B2/en active Active
- 2020-03-25 TW TW109110020A patent/TW202102533A/zh unknown
-
2021
- 2021-09-23 IL IL286620A patent/IL286620A/en unknown
-
2025
- 2025-01-17 JP JP2025006913A patent/JP2025062611A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022527267A5 (enExample) | ||
| JP2022523554A5 (enExample) | ||
| JP2022524993A5 (enExample) | ||
| JP2022524994A5 (enExample) | ||
| JP2022523552A5 (enExample) | ||
| JP2022523971A5 (enExample) | ||
| JP2022523553A5 (enExample) | ||
| Kandalaft et al. | Immunotherapy for ovarian cancer: what's next? | |
| Kershaw et al. | Gene-engineered T cells for cancer therapy | |
| EP3586852B1 (en) | Modified cell expansion and uses thereof | |
| Baxevanis et al. | Cancer immunotherapy | |
| Batlevi et al. | Novel immunotherapies in lymphoid malignancies | |
| CN106459990B (zh) | 三功能t细胞抗原偶联物及其制备方法和用途 | |
| Merhavi-Shoham et al. | Adoptive cell therapy for metastatic melanoma | |
| JP2020509767A5 (enExample) | ||
| Essand et al. | Genetically engineered T cells for the treatment of cancer | |
| JP2022524992A5 (enExample) | ||
| Tsang et al. | Phenotypic stability of a cytotoxic T-cell line directed against an immunodominant epitope of human carcinoembryonic antigen. | |
| JP2017523784A5 (enExample) | ||
| US20170232070A1 (en) | Combination Methods for Immunotherapy | |
| CN113785065B (zh) | T细胞受体及其使用方法 | |
| JP2023512452A (ja) | Ｂｃｍａ指向性細胞免疫療法組成物および方法 | |
| US11951131B2 (en) | Anti-SLAMF7 chimeric antigen receptors | |
| CN115747156A (zh) | 用于得到体内存留性和治疗活性的nkt细胞亚群以及其繁殖 | |
| KR20240032732A (ko) | 암 면역요법을 위한 투약 요법 |